Inventor
TERSTEEGEN ADRIAN
DE53 patents
⚠️ This page may combine multiple inventors who share the name “TERSTEEGEN ADRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
22 patentsUS10300062B2May 28, 2019
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG11 citations92
US9481672B2Nov 1, 2016
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG18 citations92
US10183932B2Jan 22, 2019
Substituted oxopyridine derivatives and use thereof cardiovascular disorders
Bayer Pharma AG5 citations83
US9949978B2Apr 24, 2018
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG12 citations83
US9949977B2Apr 24, 2018
Bicyclically substituted uracils and the use thereof
Bayer Pharma AG12 citations83
US9822102B2Nov 21, 2017
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
Bayer Pharma AG7 citations83
US9475809B2Oct 25, 2016
Substituted oxopyridine derivatives and use thereof as factor xia/plasma
Bayer Pharma AG6 citations83
US9434690B2Sep 6, 2016
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
Bayer Pharma AG10 citations83
US9751843B2Sep 5, 2017
Substituted uracils and use thereof
Bayer Pharma AG2 citations73
US9266871B2Feb 23, 2016
Trifluoromethyl-substituted fused pyrimidines and their use
Bayer Pharma AG5 citations73
US9918969B2Mar 20, 2018
Substituted oxopyridine derivatives and use thereof as factor XIa/plasma
Bayer Pharma AG2 citations72
US9765070B2Sep 19, 2017
Substituted oxopyridine derivatives
Bayer Pharma AG4 citations72
US9605008B2Mar 28, 2017
Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof
Bayer Pharma AG3 citations72
US10167280B2Jan 1, 2019
Substituted oxopyridine derivatives
Bayer Pharma AG2 citations71
US10138236B2Nov 27, 2018
Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
Bayer Pharma AG4 citations71
US10077265B2Sep 18, 2018
Substituted oxopyridine derivatives
Bayer Pharma AG4 citations71
US10421742B2Sep 24, 2019
Substituted oxopyridine derivatives
Bayer Pharma AG3 citations70
US10071995B2Sep 11, 2018
Substituted oxopyridine derivatives
Bayer Pharma AG3 citations70
US11884660B2Jan 30, 2024
Substituted oxopyridine derivative
Bayer Pharma AG0 citations62
US10414731B2Sep 17, 2019
Substituted oxopyridine derivatives
Bayer Pharma AG1 citations62
US11180471B2Nov 23, 2021
Substituted oxopyridine derivatives
Bayer Pharma AG0 citations59
US9688699B2Jun 27, 2017
3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
Bayer Pharma AG1 citations51
BAYER AG
7 patentsUS11773070B2Oct 3, 2023
Dihydrooxadiazinones
BAYER AG2 citations72
US11427553B2Aug 30, 2022
Dihydrooxadiazinones
BAYER AG4 citations72
US12258323B2Mar 25, 2025
Dihydrooxadiazinones
BAYER AG1 citations63
US12503491B2Dec 23, 2025
MASP inhibitory compounds and uses thereof
BAYER AG0 citations56
US11667675B2Jun 6, 2023
MASP inhibitory compounds and uses thereof
BAYER AG0 citations56
US11912692B2Feb 27, 2024
Substituted S-alaninate derivatives
BAYER AG0 citations55
US12427153B2Sep 30, 2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
BAYER AG0 citations51
HENDRIX MARTIN
6 patentsUS8158633B2Apr 17, 2012
Phenyl-substituted pyrazolopyrimidines
HENDRIX MARTIN59 citations97
US8088769B2Jan 3, 2012
Cyanopyrimidinones
HENDRIX MARTIN15 citations83
US8431573B2Apr 30, 2013
Cyanopyrimidinones
HENDRIX MARTIN2 citations62
US8822479B2Sep 2, 2014
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
HENDRIX MARTIN0 citations51
US8741907B2Jun 3, 2014
Alkyl-substituted pyrazolopyrimidines
HENDRIX MARTIN0 citations51
US8642605B2Feb 4, 2014
6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines
HENDRIX MARTIN0 citations51
BAYER IP GMBH
5 patentsUS9023849B2May 5, 2015
Substituted fused imidazoles and pyrazoles and use thereof
BAYER IP GMBH26 citations92
US9434731B2Sep 6, 2016
Imidazo-, pyrazolopyrazines and imidazotriazines and their use
BAYER IP GMBH8 citations83
US9505786B2Nov 29, 2016
Substituted annulated triazines and use thereof
BAYER IP GMBH1 citations52
US8383822B2Feb 26, 2013
Substituted oxazolidinones and their use
BAYER IP GMBH1 citations50
US8846934B2Sep 30, 2014
Substituted oxazolidinones and their use
BAYER IP GMBH0 citations48
BOEHRINGER INGELHEIM INT
4 patentsUS8039477B2Oct 18, 2011
Substituted pyrazolo[3,4-d]pyrimidin-4-one compounds as phosphodiesterase inhibitors
BOEHRINGER INGELHEIM INT63 citations96
US7615558B2Nov 10, 2009
6-arylmethylprazolo[3,4-d]pyrimidines
BOEHRINGER INGELHEIM INT31 citations92
US7488733B2Feb 10, 2009
6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
BOEHRINGER INGELHEIM INT37 citations92
US8044060B2Oct 25, 2011
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
BOEHRINGER INGELHEIM INT11 citations84
SIEGEL STEPHAN
3 patentsUS8664246B2Mar 4, 2014
Substituted pyridines, and use thereof as GSK3 inhibitors
SIEGEL STEPHAN1 citations50
US8476267B2Jul 2, 2013
Imidazo-, pyrazolopyrazines and imidazotriazines and their use
SIEGEL STEPHAN0 citations50
US8436003B2May 7, 2013
Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines
SIEGEL STEPHAN1 citations50
BAYER HEALTHCARE AG
2 patentsFOLLMANN MARKUS
1 patentShowing the top 50 of 53 patents by PatentIndex Score.